Former Executive Vice President and President, Global Human Health · Merck & Co., Inc. (MRK)

Adam Schechter

A named executive officer of Merck in every fiscal year CompBrief holds from FY2016 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$6,505,073

Salary $1,055,207Stock awards $2,764,058

FY2017: $7,850,033

4th of 5 named executive officers at Merck by FY2018 total.

5 named officers on file for Merck, FY2018

Adam Schechter’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • MRK’s disclosed peer group of 12 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Merck’s whole pay program stands against its peers

  • Merck’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MRK→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 8, 2019 (DEF 14A).

Free

Get Adam Schechter’s full pay file as a PDF — free

More than this page: up to 10 years of Adam’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Adam Schechter compensation by year

Merck Summary Compensation Table · all 3 fiscal years held
In US dollars, as Merck reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018
Salary$1,003,094$1,029,470$1,055,207
Bonus$0$0$0
Stock awards$2,493,915$2,679,655$2,764,058
Option awards$1,520,003$1,140,001$1,140,317
Non-equity incentive$1,104,012$1,229,540$1,405,267
Pension and deferred compensation$2,020,625$1,636,712$0
All other$131,398$134,655$140,224
Total$8,273,047$7,850,033$6,505,073

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Merck & Co., Inc. DEF 14A filed April 8, 2019, accession 0001140361-19-006720, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Merck & Co., Inc. filed document, accession 0001140361-19-006720. Every figure is read from that document and cited to the page and table it appears in. Filed April 8, 2019.

$8.3M
$7.9M
$6.5M
FY16
FY17
FY18
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
PSU97,668$7,462,812—
PSU83,726$6,397,504—
Option86,023—$54.68
Option108,417—$63.97
Option139,063—$57.75

Per the Outstanding Equity Awards at Fiscal Year-End table in Merck & Co., Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

Merck’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Kenneth FrazierChairman, President and Chief Executive Officer$20,934,504
Roger PerlmutterExecutive Vice President and President, Merck Research Laboratories$7,098,642
Robert DavisExecutive Vice President, Global Services and Chief Financial Officer$6,620,840
Adam Schechter · this pageFormer Executive Vice President and President, Global Human Health$6,505,073
Jennifer ZacharyExecutive Vice President and General Counsel$5,193,619

The full Merck compensation record

free company brief

This page is one person within Merck's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Merck proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Merck's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Adam Schechter's compensation dossier · One-time report. No refunds.